標(biāo)題: Titlebook: Clinical Cases in Cardiac Electrophysiology: Atrial Fibrillation and Atrial Flutter; Vol. 2 Lucian Muresan Textbook 2023 The Editor(s) (if [打印本頁(yè)] 作者: 萬(wàn)能 時(shí)間: 2025-3-21 19:05
書目名稱Clinical Cases in Cardiac Electrophysiology: Atrial Fibrillation and Atrial Flutter影響因子(影響力)
書目名稱Clinical Cases in Cardiac Electrophysiology: Atrial Fibrillation and Atrial Flutter影響因子(影響力)學(xué)科排名
書目名稱Clinical Cases in Cardiac Electrophysiology: Atrial Fibrillation and Atrial Flutter網(wǎng)絡(luò)公開(kāi)度
書目名稱Clinical Cases in Cardiac Electrophysiology: Atrial Fibrillation and Atrial Flutter網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書目名稱Clinical Cases in Cardiac Electrophysiology: Atrial Fibrillation and Atrial Flutter被引頻次
書目名稱Clinical Cases in Cardiac Electrophysiology: Atrial Fibrillation and Atrial Flutter被引頻次學(xué)科排名
書目名稱Clinical Cases in Cardiac Electrophysiology: Atrial Fibrillation and Atrial Flutter年度引用
書目名稱Clinical Cases in Cardiac Electrophysiology: Atrial Fibrillation and Atrial Flutter年度引用學(xué)科排名
書目名稱Clinical Cases in Cardiac Electrophysiology: Atrial Fibrillation and Atrial Flutter讀者反饋
書目名稱Clinical Cases in Cardiac Electrophysiology: Atrial Fibrillation and Atrial Flutter讀者反饋學(xué)科排名
作者: CRACY 時(shí)間: 2025-3-21 21:19
2DOF Controller Parameterisation, desloratadine 5?mg, esomeprazole 40?mg, paroxetine 20?mg, and paracetamol + codeine 1000/15 mg 3×/day..Her 12-lead ECG showed sinus rhythm with a heart rate of 75?bpm. Her transthoracic echocardiography showed a nondilated LV with a preserved EF% of 63% and a nondilated left atrium with a surface 作者: APO 時(shí)間: 2025-3-22 03:49 作者: 領(lǐng)巾 時(shí)間: 2025-3-22 07:24
Robust Control of Time-delay Systemslol 40?mg, apixaban 5 mg 2×/day, spironolactone 25?mg, and metformin 500 mg..Her 12-lead ECG showed sinus rhythm with a heart rate of 62?bpm, QRS axis at ?15°, no LV hypertrophy, no ischemia, incomplete right bundle branch block. Her transthoracic echocardiography showed a nondilated LV with a prese作者: Blatant 時(shí)間: 2025-3-22 10:08
Robust Control of Time-delay Systemshy showed a nondilated LV (EDD of 50?mm, ESD of 39?mm), with moderate systolic dysfunction (LVEF of 40% evaluated by single-plane Simpson method), absence of left ventricular hypertrophy (IVS thickness and posterior wall thickness of 11?mm), nonelevated LV filling pressure, E/Ea of 7, absence of sig作者: 祖?zhèn)髫?cái)產(chǎn) 時(shí)間: 2025-3-22 14:59 作者: 祖?zhèn)髫?cái)產(chǎn) 時(shí)間: 2025-3-22 21:00 作者: EXUDE 時(shí)間: 2025-3-22 23:49 作者: 神圣在玷污 時(shí)間: 2025-3-23 03:24 作者: 杠桿 時(shí)間: 2025-3-23 07:02
https://doi.org/10.1007/1-84628-265-9howed a nondilated LV, with moderate systolic dysfunction (LVEF of 42% evaluated by Simpson single-plane method), left ventricular hypertrophy (basal IVS thickness of 15?mm, with no signs of obstruction in the LVOT, posterior wall thickness of 11?mm), absence of significant valve disease, the presen作者: NAIVE 時(shí)間: 2025-3-23 12:40 作者: photopsia 時(shí)間: 2025-3-23 17:25 作者: VEN 時(shí)間: 2025-3-23 21:51
Robust Control of Uncertain Dynamic Systemscomplex QRS tachycardia, HR of 138?bpm. His transthoracic echocardiography showed a nondilated LV, with preserved systolic function (LVEF of 76% evaluated by Teichholz method), mild left ventricular hypertrophy (IVS thickness of 13?mm, posterior wall thickness of 11.5?mm), mild mitral regurgitation,作者: 有權(quán) 時(shí)間: 2025-3-24 00:57 作者: abreast 時(shí)間: 2025-3-24 06:10
https://doi.org/10.1007/978-981-19-7462-5?years. His medication at home consisted of trimethoprim–sulfamethoxazole 80/400?mg, fluindione 20?mg, Amiodarone 100?mg, Perindopril 4?mg, Bisoprolol 5?mg, Amlodipine 5?mg, ursodeoxycholic acid 750?mg, mycophenolic acid 1000?mg, tacrolimus 2?mg, and levothyrox 175?μg..His 12-lead ECG showed atrial 作者: 古文字學(xué) 時(shí)間: 2025-3-24 09:34 作者: pessimism 時(shí)間: 2025-3-24 11:37 作者: 有罪 時(shí)間: 2025-3-24 17:03
Reduced order controller design,A, complaining of dyspnea on exertion..His cardiovascular risk factors were represented by age?>?55?years, arterial hypertension, and type 2 diabetes mellitus. His medication at home consisted of metoprolol 200?mg/day, amiodarone 200?mg, aspirin 75?mg, rosuvastatin 10?mg, valsartan 80?mg, furosemide作者: 令人苦惱 時(shí)間: 2025-3-24 19:53
Duncan C. McFarlane,Keith Glover levothyroxine 25?μg, potassium supplements 600?mg, irbesartan 150?mg, and pravastatin 20 mg..His 12-lead ECG showed atrial flutter with variable AV conduction, heart rate of 84?bpm, QRS axis at +35°, LV hypertrophy (Sokolov index of 38?mm), flattened T waves in leads V5, V6. Transthoracic echocardi作者: Palter 時(shí)間: 2025-3-25 02:22
Case 1, LVEF and a nondilated left atrium..A radiofrequency catheter ablation procedure was performed, with electric isolation of the pulmonary veins. After PVI, the patient presented repetitive PAC of a single morphology, which was considered a potential extra-PVI trigger of atrial fibrillation. Their ori作者: 低能兒 時(shí)間: 2025-3-25 06:38 作者: Cpap155 時(shí)間: 2025-3-25 08:04 作者: airborne 時(shí)間: 2025-3-25 14:54
Case 4,lol 40?mg, apixaban 5 mg 2×/day, spironolactone 25?mg, and metformin 500 mg..Her 12-lead ECG showed sinus rhythm with a heart rate of 62?bpm, QRS axis at ?15°, no LV hypertrophy, no ischemia, incomplete right bundle branch block. Her transthoracic echocardiography showed a nondilated LV with a prese作者: 路標(biāo) 時(shí)間: 2025-3-25 18:42 作者: 是比賽 時(shí)間: 2025-3-25 22:00
Case 6, with a heart rate of 75?bpm, QRS axis at ?60°, left ventricular hypertrophy, and incomplete left bundle branch block. His transthoracic echocardiography showed a nondilated LV, with preserved systolic function (LVEF of 62% evaluated by the Teichholz method), severe left ventricular hypertrophy (IVS作者: ineptitude 時(shí)間: 2025-3-26 02:21
Case 7,n at home consisted of rivaroxaban 20?mg, spironolactone 25?mg, levothyroxine 75 ug, rosuvastatin 5?mg, nadolol 80?mg, and potassium supplements 1200?mg/day..Her 12-lead ECG showed atrial fibrillation with a heart rate of 140?bpm, QRS axis at-25°, no LV hypertrophy, negative T waves in V4-V6, and in作者: 閃光你我 時(shí)間: 2025-3-26 06:15 作者: 笨拙處理 時(shí)間: 2025-3-26 11:54 作者: 放棄 時(shí)間: 2025-3-26 12:47 作者: Urologist 時(shí)間: 2025-3-26 18:30
Case 11, (mild physical effort), and occurrence of bilateral lower limbs edema..His cardiovascular risk factors were represented by diabetes mellitus, age >55?years, grade 1 obesity, arterial hypertension, and dyslipidemia..His medication at home consisted of dabigatran 150 mg 2×/day, bisoprolol 5?mg/day, p作者: 絆住 時(shí)間: 2025-3-26 22:20
Case 12,ue to restriction of the posterior mitral leaflet, a trans-mitral gradient of 4?mmHg, nondilated right heart chambers, mild tricuspid regurgitation with mild pulmonary hypertension, sPAP of 39?mmHg, absence of pericardial fluid, and a nondilated ascending aorta..A radiofrequency catheter ablation pr作者: 愉快嗎 時(shí)間: 2025-3-27 04:59
Case 13,complex QRS tachycardia, HR of 138?bpm. His transthoracic echocardiography showed a nondilated LV, with preserved systolic function (LVEF of 76% evaluated by Teichholz method), mild left ventricular hypertrophy (IVS thickness of 13?mm, posterior wall thickness of 11.5?mm), mild mitral regurgitation,作者: gruelling 時(shí)間: 2025-3-27 05:25
Case 14,olol 1.25 mg..His 12-lead ECG showed showing atrial tachycardia with a 2:1 AV conduction and with a heart rate of 108?bpm, QRS axis at ?25°, absence of LV hypertrophy, and absence of ischemia. His transthoracic echocardiography showed a nondilated LV, with preserved systolic function (LVEF of 58% ev作者: 殘暴 時(shí)間: 2025-3-27 12:13 作者: PATHY 時(shí)間: 2025-3-27 14:18
Case 16,nce of the atrial tachycardia. The patient was in class EHRA 2A, complaining of fatigue and dyspnea on exertion (class EHRA 2A)..His cardiovascular risk factors were represented by arterial hypertension and age?>?55?years..His medication at home consisted of amiodarone 100?mg, rivaroxaban 20?mg, lev作者: Sedative 時(shí)間: 2025-3-27 20:34 作者: Hla461 時(shí)間: 2025-3-27 22:56
Case 18,A, complaining of dyspnea on exertion..His cardiovascular risk factors were represented by age?>?55?years, arterial hypertension, and type 2 diabetes mellitus. His medication at home consisted of metoprolol 200?mg/day, amiodarone 200?mg, aspirin 75?mg, rosuvastatin 10?mg, valsartan 80?mg, furosemide作者: intangibility 時(shí)間: 2025-3-28 02:29
Case 19, levothyroxine 25?μg, potassium supplements 600?mg, irbesartan 150?mg, and pravastatin 20 mg..His 12-lead ECG showed atrial flutter with variable AV conduction, heart rate of 84?bpm, QRS axis at +35°, LV hypertrophy (Sokolov index of 38?mm), flattened T waves in leads V5, V6. Transthoracic echocardi作者: 整潔漂亮 時(shí)間: 2025-3-28 09:22 作者: diabetes 時(shí)間: 2025-3-28 13:46 作者: CHYME 時(shí)間: 2025-3-28 17:59 作者: Congregate 時(shí)間: 2025-3-28 19:41
Robust Control of Time-delay Systemsmbolic origin in the territory of the left anterior cerebral artery (2016), and goiter treated with total thyroidectomy was referred to the Cardiology Department for treatment of her paroxysmal atrial fibrillation. Her cardiovascular risk factors were represented by grade 1 obesity, active smoking, 作者: Indent 時(shí)間: 2025-3-29 00:43 作者: covert 時(shí)間: 2025-3-29 03:54 作者: 消音器 時(shí)間: 2025-3-29 10:28
Robust Control of Time-delay Systems + stent implantation), drug-refractory symptomatic recurrent persistent atrial fibrillation responsible for 2 episodes of decompensated heart failure, treated successfully with electrical cardioversion 5?months prior, and moderate obstructive sleep apnea treated with CPAP, was admitted to the Cardi作者: Shuttle 時(shí)間: 2025-3-29 14:34 作者: Omniscient 時(shí)間: 2025-3-29 16:22
Classical Control of Time-delay Systemst persistent atrial fibrillation treated 1?year prior with catheter ablation in another center (pulmonary vein isolation and CFAE ablation), CTI ablation for typical atrial flutter, and hypothyroidism was admitted to the Cardiology Department for symptomatic recurrence of atrial fibrillation. The pa作者: 精確 時(shí)間: 2025-3-29 21:02 作者: neolith 時(shí)間: 2025-3-30 02:51
https://doi.org/10.1007/1-84628-265-9ith electrical cardioversion, with a LVEF of 65% quantified by transthoracic echocardiography 4?weeks after the electrical cardioversion, was admitted to the Cardiology Department for dyspnea on exertion, dyspnea with orthopnea, nocturnal paroxysmal dyspnea, fatigue, asthenia, and bilateral edema of作者: consent 時(shí)間: 2025-3-30 04:19 作者: 無(wú)法治愈 時(shí)間: 2025-3-30 10:53 作者: declamation 時(shí)間: 2025-3-30 13:04 作者: Congestion 時(shí)間: 2025-3-30 20:32 作者: Flu表流動(dòng) 時(shí)間: 2025-3-30 23:12 作者: PALSY 時(shí)間: 2025-3-31 01:51
Andrey V. Savkin,Ian R. Petersenl atrial flutter treated with CTI ablation at the age of 75?years, atypical atrial flutter treated with electrical cardioversion at the age of 76?years, and catheter ablation of a roof-dependent LA flutter at the age of 78?years (presented in Chap. .), amiodarone-induced hyperthyroidism, and acute i作者: 誘拐 時(shí)間: 2025-3-31 07:01 作者: EXUDE 時(shí)間: 2025-3-31 09:54
Studies in Systems, Decision and Controlbrillation since the age of 55?years, refractory to medical treatment (Amiodarone, Flecainide, Sotalol), that had progressed to persistent atrial fibrillation, treated with a first RF catheter ablation procedure (pulmonary veins isolation + CFAE ablation) in another center at the age of 57?years (20作者: cogitate 時(shí)間: 2025-3-31 16:33 作者: NOMAD 時(shí)間: 2025-3-31 17:49
Reduced order controller design,erative aortic stenosis and severe mitral regurgitation treated with aortic valve replacement with a Carpentier Edwards N°25 bioprosthetic valve and mitral valve repair with a Carpentier Edwards N°30 mitral annuloplasty ring, coronary artery disease treated with double CABG: LIMA–LAD and ISV–RCA at 作者: Bombast 時(shí)間: 2025-4-1 01:39
Duncan C. McFarlane,Keith Glovero medical treatment (Amiodarone, Propafenone, Flecainide, Sotalol, Cibenzoline, and Quinidine), treated with a RF catheter ablation procedure (pulmonary vein isolation) in another center at the age of 60?years, persistent atrial flutter post catheter ablation and hypothyroidism, was referred to the
